CompoAtlas

Noctima

Food supplement declared in France, declaration No 2020-1-862

Noctima (Yves Ponroy) is a food supplement declared in France. Status: retiré du marché le 31 December 2024. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Yves Ponroy
Food business operator placing the product on the market
HAVEA COMMERCIAL SERVICES
Status
Retiré du marché le 31 December 2024
Form
Gélule
Daily dose
2 gélules
Directions for use
à avaler avec un verre d'eau
Not recommended for (according to the manufacturer)
Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Insuffisance rénale, Nourrissons (moins de 1 an)
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil, Système nerveux

Declaration 167309, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Valeriana officinalis L.RacineExtrait sec hydroalcoolique120 mg

Other active ingredients

NamePer day
Phospholipidesnot declared
Tryptophanenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Oxyde de magnésiumMagnésium250 mg300 mg
Acétate de D-alpha-tocophéryleVitamine E300 mg30 mg

Additives

E150a, E460, E470b, E551

Other ingredients

Gélatine de poisson, maltodextrine

Has the product changed? Photograph the packaging.

Label warnings

Ne convient pas aux insuffisants rénaux. Ne convient pas aux enfants de moins de 12 ans.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Yves Ponroy

Enter to analyse, Shift+Enter for a new line